The role of global epigenetic changes in the aging process and age-related degenerative disorders is unknown. This proposal is based on the working hypothesis that specific cell types and tissues drive the aging process through global changes in the epigenome. To explore this hypothesis, we have conceived a novel system to address the methodological shortcomings that currently preclude cell-type-specific epigenetic analysis in complex tissues. The planned new approach, which we term Chromatin Isolation and Chromatin Immunoprecipitation (CI- ChIP), will involve transgenic expression of a tagged core histone in cells of interest using a cell type-specific promoter. The tagged histone would then be incorporated into the chromatin of the cells of interest, permitting the isolation of chromatin from specific cells in any animal model or complex tissue. We intend to use the nematode worm, Caenorhabditis elegans, to develop CI- ChIP. The genetic tractability and aging biology of the worm offers many advantages. Development of CI-ChIP would have immediate benefits for the study of gene expression and the epigenetics of aging in C. elegans. Furthermore, changes in gene expression during aging and under conditions that extend longevity could be measured at the tissue level for the first time. This will enable investigation of the molecular basis of differential rates of aging and the contribution of each of the major cell types in the worm. To explore the role of epigenetic changes in mammalian aging, CI-ChIP will be applied to transgenic mice expressing tagged histones targeted to tissues with pronounced age-related pathology, including the brain, heart, skeletal muscle, vasculature and pancreas. This would allow for global epigenetic analysis at cell type-specific resolution in any mouse model of disease, development or physiology. Finally, it is conceivable that CI-ChIP might lead to technology for predicting individuals at risk for age- related degenerative disorde

National Institute of Health (NIH)
National Institute on Aging (NIA)
NIH Director’s Pioneer Award (NDPA) (DP1)
Project #
Application #
Study Section
Special Emphasis Panel (ZGM1-NDPA-B (01))
Program Officer
Wise, Bradley C
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Harvard University
Schools of Medicine
United States
Zip Code
Kassam, Z; Cribb Fabersunne, C; Smith, M B et al. (2016) Clostridium difficile associated risk of death score (CARDS): a novel severity score to predict mortality among hospitalised patients with C. difficile infection. Aliment Pharmacol Ther 43:725-33
Lu, Tao; Aron, Liviu; Zullo, Joseph et al. (2014) REST and stress resistance in ageing and Alzheimer's disease. Nature 507:448-54
Mosammaparast, Nima; Kim, Haeyoung; Laurent, Benoit et al. (2013) The histone demethylase LSD1/KDM1A promotes the DNA damage response. J Cell Biol 203:457-70
Gabuzda, Dana; Yankner, Bruce A (2013) Physiology: Inflammation links ageing to the brain. Nature 497:197-8
Lee, Peter C W; Dodart, Jean-Cosme; Aron, Liviu et al. (2013) Altered social behavior and neuronal development in mice lacking the Uba6-Use1 ubiquitin transfer system. Mol Cell 50:172-84
Sun, Fang; Park, Kevin K; Belin, Stephane et al. (2011) Sustained axon regeneration induced by co-deletion of PTEN and SOCS3. Nature 480:372-5
Haigis, Marcia C; Yankner, Bruce A (2010) The aging stress response. Mol Cell 40:333-44
Bishop, Nicholas A; Lu, Tao; Yankner, Bruce A (2010) Neural mechanisms of ageing and cognitive decline. Nature 464:529-35
Lipinski, Marta M; Zheng, Bin; Lu, Tao et al. (2010) Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease. Proc Natl Acad Sci U S A 107:14164-9